Home/Filings/4/0000950170-24-132976
4//SEC Filing

Goldshleger Ilya 4

Accession 0000950170-24-132976

CIK 0001111485other

Filed

Dec 2, 7:00 PM ET

Accepted

Dec 3, 6:38 PM ET

Size

9.4 KB

Accession

0000950170-24-132976

Insider Transaction Report

Form 4
Period: 2024-11-29
Goldshleger Ilya
See remarks
Transactions
  • Sale

    Common Stock

    2024-11-29$46.08/sh3,105$143,07842,246 total
  • Exercise/Conversion

    Common Stock

    2024-11-29$15.08/sh+3,105$46,82345,351 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2024-11-293,10540,777 total
    Exercise: $15.08Exp: 2030-04-22Common Stock (3,105 underlying)
Holdings
  • Common Stock

    (indirect: By Spouse)
    1,372
Footnotes (2)
  • [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on June 3, 2024 by the Reporting Person.
  • [F2]Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2015 Equity Incentive Plan, as amended) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean April 23, 2020.

Documents

1 file

Issuer

RxSight, Inc.

CIK 0001111485

Entity typeother

Related Parties

1
  • filerCIK 0001874147

Filing Metadata

Form type
4
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 6:38 PM ET
Size
9.4 KB